Results 171 to 180 of about 5,683,627 (357)

NR4A1 Exerts Pro‐Tumor Role in Glioblastoma via Inducing xCT/GPX4‐Regulated Ferroptosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Purpose This study investigates NR4A1's paradoxical roles in glioblastoma (GBM) progression, focusing on its mechanistic link to ferroptosis regulation. We aimed to resolve conflicting reports of NR4A1 as both an oncogene and a tumor suppressor by defining its transcriptional control over xCT/GPX4‐mediated iron homeostasis and its clinical ...
Peng Tao, Shikuan Din, Zhengkang Fu, Qian Sun, Xiwei Zhu, Yuxin Wei, Huan Qu, Xinyi Zhang, Jiaxuan Liu, Chuhua Fu, Qianxue Chen   +10 more
wiley   +1 more source

Opn3 Drives Blue-Light-Induced Reduction in Lipid Droplets and Antiviral Defense. [PDF]

Biomolecules
Wu Q, Liu H, Liang H, Jiang X, Qin Y, Liang S, Wang J, Liu K.   +7 more
europepmc   +1 more source

The Preventive Power of the Mediterranean Diet Against Blue-Light-Induced Retinal Degeneration: Is the Secret in the Herbs and Spices? [PDF]

Anja Harej, Ana Pelčić, Tea Čaljkušić‐Mance, Jasenka Mršić‐Pelčić, Kristina Pilipović   +4 more
openalex   +1 more source

Enhanced blue-green response of nanoarray AlGaAs photocathodes for underwater low-light detection

, 2023
Shiman Li, Yijun Zhang, Ziheng Wang, Dongzhi Wang, Song Tang, Junju Zhang, Feng Shi, Gangcheng Jiao, Hongchang Cheng, Guanghui Hao   +9 more
openalex   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

Illuminating the regulatory link between blue light and autophagy in photomorphogenesis. [PDF]

Autophagy Rep
Jiang L, Yang HQ, Wang W.
europepmc   +1 more source

Cross‐Linked Conjugated Polymers for Achieving Patterned Three‐Color and Blue Polymer Light‐Emitting Diodes with Multi‐Layer Structures [PDF]

, 2009
Xianyu Deng, King Young Wong
openalex   +1 more source

The Case of a 28‐Year‐Old Woman With Medically Refractory Focal Epilepsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT We present the case of a 28‐year‐old right‐handed woman with medically refractory focal epilepsy. Her seizure semiology and electroencephalography (EEG) indicated a seizure onset zone in the right central‐parietal area. However, both MRI and PET scans were unremarkable, showing no focal lesions or areas of altered metabolism.
Rishi Sharma, Ilo Leppik, Thomas Henry, Thaddeus Walczak, Sima Patel, Robert McGovern   +5 more
wiley   +1 more source

Blue-light-filtering spectacle lenses in managing vision-related symptoms: an updated review. [PDF]

Ther Adv Ophthalmol
Khorrami-Nejad M, Naroo SA, Oklla A, Narooie-Noori F.   +3 more
europepmc   +1 more source

Chronological and Spatial Distribution of Skeletal Muscle Fat Replacement in FHL1‐Related Myopathies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Variants in the FHL1 gene cause FHL1‐related myopathies (FHL1‐RMs), a group of neuromuscular disorders with diverse clinical presentations. This study aimed to comprehensively characterize the spatial and temporal patterns of skeletal muscle fat replacement throughout the whole body in FHL1‐RMs, to examine disease progression over ...
Rui Shimazaki, Satoru Noguchi, Hotake Takizawa, Yasushi Oya, Yuji Takahashi, Hirofumi Komaki, Hajime Arahata, Shinichiro Hayashi, Ichizo Nishino   +8 more
wiley   +1 more source